Today on the Internet
SEE OTHER BRANDS

Fresh internet news from the world

Today on the Internet: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today on the Internet.

Press releases published on May 23, 2025

VIRTUNE ACCELERATES EUROPEAN EXPANSION WITH XRP ETP DEBUT ON DEUTSCHE BÖRSE XETRA

VIRTUNE ACCELERATES EUROPEAN EXPANSION WITH XRP ETP DEBUT ON DEUTSCHE BÖRSE XETRA

Frankfurt, 23 May 2025 – Swedish regulated crypto asset manager Virtune brings its flagship Virtune XRP ETP to Germany's premier trading venue Deutsche Börse Xetra, extending its regulated digital asset offerings to Europe's largest economy. With strong …

Music Streaming Market is Expanding Rapidly with 17.3% CAGR by 2032, Driven by On-Demand Audio and Subscription Growth

Music Streaming Market is Expanding Rapidly with 17.3% CAGR by 2032, Driven by On-Demand Audio and Subscription Growth

Burlingame, CA, May 23, 2025 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, the global Music Streaming Market size is calculated at USD 47.06 billion in 2025 and is forecasted to reach around USD 143.89 billion by 2032, …

Inventiva reports 2025 First Quarter Financial Information¹

Inventiva reports 2025 First Quarter Financial Information¹

Cash and cash equivalents at €67.9 million Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral …

Inventiva publie ses informations financières¹ du 1er trimestre 2025

Inventiva publie ses informations financières¹ du 1er trimestre 2025

Trésorerie et équivalents de trésorerie à 67,9 millions d’euros Daix (France), New York City (New York, Etats-Unis), le 23 mai 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans …

Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025

Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025

Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic …

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunies le 22 mai 2025

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunies le 22 mai 2025

Daix (France), New York City (New York, Etats-Unis), le 23 mai 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la …

Endeavour Announces Results of Annual General Meeting 2025

Endeavour Announces Results of Annual General Meeting 2025

ENDEAVOUR ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING 2025 London, 23 May 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) (“the Company”) is pleased to announce that all resolutions at yesterday's annual general meeting (“AGM”) were duly passed …

OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025

OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025

OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025 BI 765063 in combination with programmed …

OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours

OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours

OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours sur la modulation de l’immunité innée et l’activité antitumorale via le blocage de SIRPα à l’ASCO 2025 BI …

Aurio Expands Integrated Business Services Portfolio with New Finance Operations Segment

Aurio Expands Integrated Business Services Portfolio with New Finance Operations Segment

Cherry Hill, NJ, May 23, 2025 (GLOBE NEWSWIRE) -- Aurio, an innovative business services company, has expanded its offerings with the launch of a new Finance Operations segment, delivering a full finance stack to help clients manage financial performance …

Self-driving Cars Market worth 76,217 thousand units in 2032, Globally, at a CAGR of 6.8%, says MarketsandMarkets™

Self-driving Cars Market worth 76,217 thousand units in 2032, Globally, at a CAGR of 6.8%, says MarketsandMarkets™

Delray Beach, FL, May 22, 2025 (GLOBE NEWSWIRE) -- Self-Driving Cars Market is projected to reach from 37,090 thousand units in 2024 to 76,217 thousand units in 2035, at a CAGR of 6.8%, as per the recent study by MarketsandMarkets™.  The self-driving cars …

CECOCECO to Unveil ArtMorph Innovation at AIA Conference on Architecture & Design 2025

CECOCECO to Unveil ArtMorph Innovation at AIA Conference on Architecture & Design 2025

BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- CECOCECO, a leading innovator in the lighting and display industry, is excited to announce its participation in the AIA Conference on Architecture …

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service